No cost modification to change the period of performance end date for clin 2 to september 29, 2026.
Ended Awarded Last action
- Contract number
- 75F40124F19014
- Awardee
-
Harvard Pilgrim Health Care, Inc. UEI NZVVQ8GNVX65
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $365,500
Award facts
- Contract value 1% obligated
- $25,692,680.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Wellesley Hills, Wellesley, MA 02481, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $365,500 | |
| Other Administrative Action | $0 | |
| Original award | $25,327,180 |
About this award
Harvard Pilgrim Health Care Inc. has been awarded a no-cost modification to a delivery order contract with the Food and Drug Administration (FDA) extending the period of performance for CLIN 2 through September 29, 2026. The contract, valued at $25.7 million on a firm fixed-price basis, supports continuation of the FDA's Sentinel System, a critical post-market medical product safety surveillance program. Services include operations and maintenance of the ARIA System, management of real-world evidence claims and electronic health record linked data, program and project management, follow-on assessments related to the Prescription Drug User Fee Act VII, website operations and maintenance, training, and the annual Sentinel System workshop. The work will be performed in Wellesley Hills, Massachusetts, with no set-aside designation applied to this award.
The modification reflects the FDA's ongoing reliance on Harvard Pilgrim Health Care Inc.'s specialized expertise in pharmacoepidemiology, health informatics, and surveillance data analytics to support the Sentinel System's essential mission. As a non-profit healthcare research organization, Harvard Pilgrim brings substantial capabilities in epidemiological research and public health data management, having established itself as a key federal partner through previous contracts with the FDA and Centers for Disease Control and Prevention. This delivery order extension ensures continuity of critical safety surveillance infrastructure that supports post-market monitoring of drugs, biologics, and medical devices across the United States healthcare system.
Quick answers
Who was awarded contract 75F40124F19014?
75F40124F19014 was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 20, 2024.
How much is contract 75F40124F19014 worth?
The government has obligated $365,500 on 75F40124F19014. Its current value, with exercised options, is $25,692,680.
Is contract 75F40124F19014 an order under another contract?
Yes. 75F40124F19014 is a delivery order under 75F40119D10037, an indefinite delivery contract.
Was contract 75F40124F19014 competed?
The extent of competition for 75F40124F19014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award